Dec 27, 2022
In this episode, we welcome the lead author of “Deucravacitinib, a Tyrosine Kinase 2 Inhibitor, in Systemic Lupus Erythematosus: A phase 2, Randomized, Double-Blind, Placebo-Controlled Trial” Dr. Eric Morand of Monash University. The objective of this multicenter clinical trial in lupus (recently published in “
Dec 13, 2022
Join us this week as we interview the lead author of “Genicular Nerve Block for Pain Management in Patients with Knee Osteoarthritis: A Randomized Placebo-Controlled Trial”, Dr. Michael Shanahan. Dr. Shanahan’s study, most recently published in “Arthritis & Rheumatology” attempts to determine the efficacy of...
Nov 29, 2022
This week, our guest is Dr. Grace Lo, first author of “Association Between Walking for Exercise and Symptomatic and Structural Progression in Individuals with Knee Osteoarthritis: Data from the Osteoarthritis Initiative Cohort” And Assistant Professor at Baylor College of Medicine. The objective of her study:...
Nov 15, 2022
This week on ‘Journals’, Dr. Shanmugam has invited Dr Joann B Sweasy and Dr. Westley Reeves to discuss a paper with an interesting journey, “A Human MSH6 Germline Variant Associated with Systemic Lupus Erythematosus Induces Lupus-Like Disease in Mice“. In this paper, we discover that the science is always...
Nov 1, 2022
In this week’s episode, Dr. Shanmugam welcomes Dr. Mary Beth Son, the senior author and corresponding author of “Treatment of Multisystem Inflammatory Syndrome in Children: Understanding Differences in Results of Comparative Effectiveness Studies.” This study sought to determine whether the application of differe